elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38979882-4B78E465-AE54-4EE9-84B9-9D331355BB6F
Q38979882-4B78E465-AE54-4EE9-84B9-9D331355BB6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-4B78E465-AE54-4EE9-84B9-9D331355BB6F
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
P2860
Q38979882-4B78E465-AE54-4EE9-84B9-9D331355BB6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-4B78E465-AE54-4EE9-84B9-9D331355BB6F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2763e4c0e26e27b3af790892a90a869f6ed45005
P2860
FGF receptor inhibitors: role in cancer therapy.